SCHEMBL1468360

SCHEMBL1468360

COc1ccc(C=O)cc1-c1ccnc(Cl)n1.Clc1ccnc(Cl)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.43
MAPT P10636 5/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
FDPS P14324 1/20 0.42
AOX1 Q06278 1/20 0.40
CYP1A2 P05177 2/20 0.39
AGPAT2 O15120 1/20 0.38
HPGD P15428 4/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TRIM24 O15164 1/20 0.38
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3399379 0.95 ALDH1A1 (0.51) ALDH1A1GAATSHRMAPTMEN1
SCHEMBL1468270 0.84 ALDH1A1 (0.34) ALDH1A1GAAMAPTMEN1KMT2A
SCHEMBL1467777 0.78 KMO (0.46) ALDH1A1GAAMEN1KMT2AL3MBTL1
SCHEMBL3400718 0.78 ALDH1A1 (0.37) ALDH1A1GAAPOLBLMNA
SCHEMBL1033197 0.77 ALDH1A1 (0.55) ALDH1A1MEN1KMT2AAGPAT2HPGD
SCHEMBL3625797 0.76 CDK9 (0.44) ALDH1A1TSHRCYP1A2CYP2D6CYP2C19
SCHEMBL3624500 0.76 AGPAT2 (0.42) ALDH1A1GAAMAPTMEN1KMT2A
SCHEMBL31011561 0.76 AGPAT2 (0.42) ALDH1A1GAAMAPTMEN1KMT2A
SCHEMBL16241508 0.76 ERN1 (0.39) ALDH1A1GAAMEN1KMT2AL3MBTL1
SCHEMBL1466675 0.73 DYRK1A (0.42) ALDH1A1MAPTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071134-A1 2-(AMINO-SUBSTITUTED)-4-ARYL PYRIMIDINES AND RELATED COMPOUNDS USEFUL FOR TREATING INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071134-A1 2-(AMINO-SUBSTITUTED)-4-ARYL PYRIMIDINES AND RELATED COMPOUNDS USEFUL FOR TREATING INFLAMMATORY DISEASES PRKCZ, PRKCQ, PRKCE ALDH1A1 4044/4885GAA 2759/4885TSHR 3806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.